CTGLF inhibitors are a diverse group of chemicals that indirectly influence the activity of the CTGLF protein, which is encoded by the CTGLF gene. This group of inhibitors does not directly interact with the CTGLF protein. Instead, they modulate various signaling pathways and cellular processes that can, in turn, influence the function of CTGLF. These inhibitors are characterized by their varied mechanisms of action, reflecting the complex and interconnected nature of cellular signaling networks.
The inhibitors listed here encompass a wide range of chemical entities, each with a unique mode of action. For example, Lithium Carbonate, known to affect the Wnt signaling pathway, and Forskolin, which enhances cAMP levels, demonstrate how changes in key signaling molecules can have downstream effects on proteins like CTGLF. Similarly, Ibuprofen and Sulindac, through their roles in modulating inflammatory responses, illustrate the impact of inflammation on protein functions.
Antioxidants like Epicatechin highlight the influence of oxidative stress on cellular processes, including those involving CTGLF. In contrast, compounds like Genistein and Pioglitazone demonstrate how inhibitors can affect protein function by modulating tyrosine kinase activity and lipid metabolism, respectively.
Moreover, compounds such as Capsaicin, which affects pain signaling, and Cimetidine, influencing histamine pathways, show the diverse physiological processes that can indirectly impact the activity of proteins like CTGLF. Simvastatin, by influencing cholesterol biosynthesis, and Nicotine, affecting cholinergic signaling, further illustrate the wide array of mechanisms through which CTGLF inhibitors can operate.
In summary, the chemical class of "CTGLF Inhibitors" encompasses a broad spectrum of compounds that, through various indirect mechanisms, can modulate the activity of the CTGLF protein. This class exemplifies the complexity of protein regulation in biological systems, where multiple pathways and processes converge to influence protein function. Understanding these intricate relationships is crucial for grasping the broader context of protein activity and its regulation in the cellular environment.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | ¥2414.00 | ||
可能会影响 Wnt 信号传导,从而可能影响 CTGLF 在这一途径中的作用。 | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | ¥857.00 ¥1692.00 ¥8179.00 ¥15626.00 ¥23128.00 | 73 | |
激活腺苷酸环化酶,导致 cAMP 增加,从而间接影响 CTGLF 的活性。 | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | ¥587.00 ¥970.00 | 6 | |
可能会改变炎症途径,从而可能影响 CTGLF 在这些过程中的作用。 | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | ¥293.00 ¥1038.00 ¥1354.00 ¥3497.00 ¥5641.00 ¥10244.00 ¥20545.00 | 46 | |
作为一种酪氨酸激酶抑制剂,可能会间接影响 CTGLF 的信号通路。 | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | ¥1015.00 | 1 | |
可能会调节代谢途径,间接影响 CTGLF 在这些过程中的作用。 | ||||||
Sulindac | 38194-50-2 | sc-202823 sc-202823A sc-202823B | 1 g 5 g 10 g | ¥350.00 ¥948.00 ¥1658.00 | 3 | |
通过调节炎症途径,可间接影响 CTGLF 的功能。 | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | ¥609.00 ¥1388.00 | 13 | |
作为 PPAR-gamma 激动剂,可能会通过调节脂质代谢间接影响 CTGLF。 | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | ¥1061.00 ¥1952.00 ¥2877.00 ¥4772.00 | 26 | |
可能会影响疼痛信号通路,间接影响 CTGLF 在这些过程中的作用。 | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | ¥338.00 ¥982.00 ¥1489.00 ¥4896.00 | 13 | |
通过影响胆固醇生物合成途径,可能会间接影响 CTGLF 的活性。 | ||||||
Cimetidine | 51481-61-9 | sc-202996 sc-202996A | 5 g 10 g | ¥699.00 ¥970.00 | 1 | |
可能会影响组胺信号通路,从而间接影响 CTGLF。 |